ODTUnknown
Odonate Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Odonate Therapeutics, Inc. (ODT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ODT insiders buying or selling?
Odonate Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 51 Form 4 filings for ODT: 46 buys ($148.5M) and 5 sells ($20.3M).
Source: SEC EDGAR Form 4
Key Statistics (February 2018 – Dec 10, 2021)
Total Form 4 filings
51
SEC EDGAR
Insider filers
6
Insider buys (46)
$148.5M
Insider sells (5)
$20.3M
Insider sentiment
Net buyingNet insider flow of $128.1M in net buying since February 2018.
Recent ODT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | EcoR1 Capital, LLC | 10% Owner | Sale | 5.7M | $1.65 | $9.4M | SEC ↗ |
| Nov 24, 2021 | Joseph Lewis | 10% Owner | Sale | 400.0K | $1.56 | $623.3K | SEC ↗ |
| Nov 20, 2021 | Aaron I. Davis | Director, 10% Owner | Sale | 1.2M | $2.08 | $2.5M | SEC ↗ |
| Nov 20, 2021 | Joseph Lewis | Director, 10% Owner | Sale | 1.0M | $2.06 | $2.1M | SEC ↗ |
| Nov 19, 2021 | Kevin C Tang | Chief Executive Officer | Sale | 2.7M | $2.09 | $5.7M | SEC ↗ |
| Dec 31, 2020 | Craig A Johnson | Director | Purchase | 3.0K | $17.00 | $51.0K | SEC ↗ |
| Dec 30, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 400.0K | $17.16 | $6.9M | SEC ↗ |
| Dec 30, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 400.0K | $17.16 | $6.9M | SEC ↗ |
| Dec 23, 2020 | TANG KEVIN C | Chief Executive Officer | Purchase | 275.8K | $15.16 | $4.2M | SEC ↗ |
| Sep 30, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 215.2K | $13.63 | $2.9M | SEC ↗ |
| Sep 30, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 215.2K | $13.63 | $2.9M | SEC ↗ |
| Sep 30, 2020 | TANG KEVIN C | Chief Executive Officer | Purchase | 110.9K | $13.13 | $1.5M | SEC ↗ |
| Sep 9, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 225.0K | $14.98 | $3.4M | SEC ↗ |
| Sep 9, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 225.0K | $14.98 | $3.4M | SEC ↗ |
| Sep 1, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 1.4M | $14.25 | $20.0M | SEC ↗ |
| Sep 1, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 1.4M | $14.25 | $20.0M | SEC ↗ |
| Sep 1, 2020 | TANG KEVIN C | Chief Executive Officer | Purchase | 1.1M | $14.25 | $15.0M | SEC ↗ |
| Jun 28, 2019 | Boxer Capital, LLC | 10% Owner | Purchase | 384.6K | $26.00 | $10.0M | SEC ↗ |
| Jun 28, 2019 | Jeff L Vacirca | Director | Purchase | 19.2K | $26.00 | $500.0K | SEC ↗ |
| Jun 28, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 769.2K | $26.00 | $20.0M | SEC ↗ |
| Jun 19, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 50.0K | $26.15 | $1.3M | SEC ↗ |
| Jun 10, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 76.3K | $27.36 | $2.1M | SEC ↗ |
| Jun 5, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 93.7K | $24.92 | $2.3M | SEC ↗ |
| Mar 11, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 140.0K | $18.26 | $2.6M | SEC ↗ |
| Mar 7, 2019 | Jeff L Vacirca | Director | Purchase | 3.0K | $17.00 | $51.0K | SEC ↗ |
Showing the 25 most recent of 51 Form 4 filings for Odonate Therapeutics, Inc..
Most active ODT insiders
- TANG KEVIN C29 filings
- Boxer Capital, LLC10 filings
- Aaron I. Davis8 filings
- Jeff L Vacirca2 filings
- Craig A Johnson1 filing
Ask anything about ODT insider activity
Use Trabud's AI agent to query Odonate Therapeutics, Inc.'s Form 4 history in plain English — "Show me ODT CEO purchases this year" or compare it against any other ticker.
Open the AI agentODT insider trading FAQ
Are Odonate Therapeutics, Inc. insiders buying or selling?
Odonate Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 51 Form 4 filings for ODT: 46 buys ($148.5M) and 5 sells ($20.3M). Over the full record that is net buying of $128.1M.
How many insiders trade ODT stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Odonate Therapeutics, Inc.. The most recent filing was accepted on Dec 10, 2021.
Where does Trabud get ODT insider trading data?
All ODT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.